Jin Ru Yan
Directeur/Membre du Conseil chez JYAMS PET Research & Development Ltd.
Provenance du réseau au premier degré de Jin Ru Yan
Entité | Type d'entité | Industrie | |
---|---|---|---|
Mitro Biotech Co., Ltd.
Mitro Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Mitro Biotech Co., Ltd. engages in contract research for new drug development using radiolabeling and molecular imaging technique. It offers drug screening, biodistribution, pharmacokinetics, pharmacodynamics, translational research service, pre-clinical services, clinical services, and regulatory services. The company was founded on November 29, 2012 and is headquartered in Nanjing, China.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
JYAMS PET Research & Development Ltd.
JYAMS PET Research & Development Ltd. Pharmaceuticals: MajorHealth Technology JYAMS PET Research & Development Ltd. engages in the production and sales of radiopharmaceuticals. Its business includes technology development and technology transfer of positron tracer and molecular probe. The company was founded on March 7, 2006 and is headquartered in Nanjing, China.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jin Ru Yan via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. | Pharmaceuticals: Major | Director/Board Member Corporate Secretary Chief Executive Officer | |
Shandong University of Finance & Economics | College/University | Undergraduate Degree | |
Tianjin University | College/University | Undergraduate Degree | |
Yantai Dongcheng Dayang Pharmaceutical Co. Ltd.
Yantai Dongcheng Dayang Pharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Part of Yantai Dongcheng Biochemicals Co., Ltd., Yantai Dongcheng Dayang Pharmaceutical Co. Ltd. is a company that manufactures medicines. The company is based in Yantai, China. | Pharmaceuticals: Other | Director/Board Member | |
Chengdu Yunke Pharmaceutical Co.
Chengdu Yunke Pharmaceutical Co. Miscellaneous Commercial ServicesCommercial Services Part of Yantai Dongcheng Biochemicals Co., Ltd., Chengdu Yunke Pharmaceutical Co. engages in biotechnology development operation. The company is based in Chengdu, China. Chengdu Yunke Pharmaceutical was acquired by Yantai Dongcheng Biochemicals Co., Ltd. on April 21, 2015 for $170.69 million. | Miscellaneous Commercial Services | Director/Board Member | |
JIANGSU BIOPERFECTUS TECHNOLOGIES CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Beijing University of Posts & Telecommunications | College/University | Masters Business Admin | |
Southern Medical University | College/University | Undergraduate Degree | |
Shanghai Lanacheng Biotechnology Co., Ltd.
Shanghai Lanacheng Biotechnology Co., Ltd. Packaged SoftwareTechnology Services Founded in 2021, Shanghai Lanacheng Biotechnology Co., Ltd. is a subsidiary of Yantai Dongcheng Biochemicals Co., Ltd. that provides technology solution services. The company is based in Shanghai, China. | Packaged Software | Director/Board Member | |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Beijing Ams Electronics Co.,Ltd. | Corporate Officer/Principal | ||
XingImaging LLC (Connecticut)
XingImaging LLC (Connecticut) Miscellaneous Commercial ServicesCommercial Services XingImaging LLC is a full-service CRO company based in Madison, CT. XingImaging provides the capability for PET radiotracer production and PET acquisition, supporting multi-center trials in the US and China, which require PET for study eligibility, disease evaluation, and treatment efficacy. The PET production facilities in the XingImaging network are located at class-4 hospitals in China, and the company is currently expanding to other regions. XingImaging is committed to producing radiotracers to support clinical trials in Alzheimer's disease. The company was founded in 2018 by Gilles Tamagnan, Piu Chan, John Seibyl, and Kenneth Marek, with Gilles Tamagnan serving as the CEO since then. The company has established a network of radiopharmaceutical tracer production and imaging centers for PET acquisition and image analysis, utilizing the most advanced neuroimaging tracer compounds available to be used in AD clinical trials. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiques
Internationale
Chine | 10 |
Etats-Unis | 3 |
Sectorielle
Health Technology | 5 |
Consumer Services | 5 |
Commercial Services | 3 |
Technology Services | 2 |
Opérationnelle
Director/Board Member | 13 |
Chief Executive Officer | 4 |
Corporate Secretary | 3 |
Undergraduate Degree | 3 |
Public Communications Contact | 2 |
Relations les plus connectées
Insiders | |
---|---|
Zhi Gang Luo | 8 |
Xing Hua Bai | 6 |
Xiao Jie Liu | 3 |
Gilles Tamagnan | 2 |
Yi Zhi Li | 1 |
Xiao Dan Wang | 1 |
Da Jun Zhuang | 1 |
- Bourse
- Insiders
- Jin Ru Yan
- Connexions Sociétés